{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-10986"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-10986","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Screening Pathological Protein Specific Antibodies as Biomarker Discovery Tools for Neurodegenerative Disease","abstract":"With the increase in the average life span, the incidence of neurodegenerative diseases also increases, among which Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common types of neurological disorders. AD and PD share the same pathogenic mechanism that involves a class of proteins called beta-amyloid (Aβ), which, under the induction of some factors, changes from its natural monomeric state to the oligomers containing β-sheet, which is neurotoxic and thus leads to cell damage or apoptosis. This study focused on the selection of antibodies used as biomarkers for AD and PD. The selection of antibodies was based on the two well-accepted biomarkers of AD and PD, i.e., Aβ proteins and α-synuclein (α-syn) Isothermal titration calorimetry (ITC) was used to determine the specific binding of individual antibodies to their target proteins.","abstract_html":"With the increase in the average life span, the incidence of neurodegenerative diseases also increases, among which Alzheimer&#x27;s disease (AD) and Parkinson&#x27;s disease (PD) are the two most common types of neurological disorders. AD and PD share the same pathogenic mechanism that involves a class of proteins called beta-amyloid (Aβ), which, under the induction of some factors, changes from its natural monomeric state to the oligomers containing β-sheet, which is neurotoxic and thus leads to cell damage or apoptosis. This study focused on the selection of antibodies used as biomarkers for AD and PD. The selection of antibodies was based on the two well-accepted biomarkers of AD and PD, i.e., Aβ proteins and α-synuclein (α-syn) Isothermal titration calorimetry (ITC) was used to determine the specific binding of individual antibodies to their target proteins.","abstract_has_math":false,"creators":["Li, Yitong"],"institution":"University of South Florida","degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":["Chuanhai Cao, Ph.D.","Umesh Jinwal, Ph.D.","Wanling Zhou, Ph.D.","Qingyu Xuan, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-10-20T07:00:00Z","date_published":"2022-10-20T07:00:00Z","updated_at":"2026-11-19T08:48:36Z","subjects":["Alzheimer’s disease","beta-amyloid","Parkinson’s disease","α-synuclein","Medicinal Chemistry and Pharmaceutics"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/9789","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/9789","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-10986","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Chuanhai Cao, Ph.D.","Umesh Jinwal, Ph.D.","Wanling Zhou, Ph.D.","Qingyu Xuan, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Li, Yitong"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022-10-20T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Alzheimer’s disease","beta-amyloid","Parkinson’s disease","α-synuclein","Medicinal Chemistry and Pharmaceutics"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/9789"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["With the increase in the average life span, the incidence of neurodegenerative diseases also increases, among which Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common types of neurological disorders. AD and PD share the same pathogenic mechanism that involves a class of proteins called beta-amyloid (Aβ), which, under the induction of some factors, changes from its natural monomeric state to the oligomers containing β-sheet, which is neurotoxic and thus leads to cell damage or apoptosis. This study focused on the selection of antibodies used as biomarkers for AD and PD. The selection of antibodies was based on the two well-accepted biomarkers of AD and PD, i.e., Aβ proteins and α-synuclein (α-syn) Isothermal titration calorimetry (ITC) was used to determine the specific binding of individual antibodies to their target proteins."]},{"key":"dc:title","label":"Title","values":["Screening Pathological Protein Specific Antibodies as Biomarker Discovery Tools for Neurodegenerative Disease"]}]}],"canonical_facts":{"dc:contributor":["Chuanhai Cao, Ph.D.","Umesh Jinwal, Ph.D.","Wanling Zhou, Ph.D.","Qingyu Xuan, Ph.D."],"dc:creator":["Li, Yitong"],"dc:date":["2022-10-20T07:00:00Z"],"dc:description":["With the increase in the average life span, the incidence of neurodegenerative diseases also increases, among which Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common types of neurological disorders. AD and PD share the same pathogenic mechanism that involves a class of proteins called beta-amyloid (Aβ), which, under the induction of some factors, changes from its natural monomeric state to the oligomers containing β-sheet, which is neurotoxic and thus leads to cell damage or apoptosis. This study focused on the selection of antibodies used as biomarkers for AD and PD. The selection of antibodies was based on the two well-accepted biomarkers of AD and PD, i.e., Aβ proteins and α-synuclein (α-syn) Isothermal titration calorimetry (ITC) was used to determine the specific binding of individual antibodies to their target proteins."],"dc:identifier":["https://digitalcommons.usf.edu/etd/9789"],"dc:subject":["Alzheimer’s disease","beta-amyloid","Parkinson’s disease","α-synuclein","Medicinal Chemistry and Pharmaceutics"],"dc:title":["Screening Pathological Protein Specific Antibodies as Biomarker Discovery Tools for Neurodegenerative Disease"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["Thesis","M.S."],"thesis:degree_name":["Master of Science (M.S.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:48:36Z"}